Australia markets open in 7 hours 59 minutes

Nephros, Inc. (NEPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0650+0.0050 (+0.24%)
As of 10:11AM EDT. Market open.

Nephros, Inc.

380 Lackawanna Place
South Orange, NJ 07079
United States
201 343 5202
https://www.nephros.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full-time employees31

Key executives

NameTitlePayExercisedYear born
Mr. Robert BanksPresident, CEO & Director474.04kN/A1975
Ms. Judy F. Krandel C.F.A.Chief Financial Officer147.01kN/A1965
Mr. Alfred VargasDirector of OperationsN/AN/AN/A
Brianne McGuireDirector of Brand, Marketing & Business DevelopmentN/AN/AN/A
Vashone R. ThomasVice President of Quality, Regulatory, & Human ResourcesN/AN/AN/A
Mr. Daron G. Evans M.B.A., M.S.Chief Executive Officer of Specialty Renal Products, Inc300.18kN/A1974
Mr. Greg LucasPresident of Aether Water SystemsN/AN/AN/A
Ms. Judy MazziniControllerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

Corporate governance

Nephros, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.